.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

IZBA Drug Profile

« Back to Dashboard
Izba is a drug marketed by Alcon Labs Inc and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge.

This drug has twenty-five patent family members in nineteen countries.

The generic ingredient in IZBA is travoprost. There are fourteen drug master file entries for this compound. Three suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the travoprost profile page.

Summary for Tradename: IZBA

Patents:4
Applicants:1
NDAs:1
Drug Prices: :see details
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon Labs Inc
IZBA
travoprost
SOLUTION/DROPS;OPHTHALMIC204822-001May 15, 2014DISCNNo9,144,561► subscribeY ► subscribe
Alcon Labs Inc
IZBA
travoprost
SOLUTION/DROPS;OPHTHALMIC204822-001May 15, 2014DISCNNo8,754,123► subscribeY ► subscribe
Alcon Labs Inc
IZBA
travoprost
SOLUTION/DROPS;OPHTHALMIC204822-001May 15, 2014DISCNNo8,722,735► subscribeY ► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: IZBA

Drugname Dosage Strength RLD Submissiondate
travoprostOphthalmic Solution0.003%Izba12/30/2015

International Patent Family for Tradename: IZBA

Country Document Number Estimated Expiration
European Patent Office2705836► subscribe
Germany202009019114► subscribe
South Korea20110005801► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: IZBA

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2012017,C1920764Lithuania► subscribePRODUCT NAME: TRAVOPROSTUM; NAT. REGISTRATION NO/DATE: LT 02/7821/3 20020402; FIRST REGISTRATION: EU/1/01/199/001 - EU/1/01/199/002 20011127
C/GB12/038United Kingdom► subscribePRODUCT NAME: TRAVOPROST; REGISTERED: UK EU/1/01/199/001-002 20011129
2012017Lithuania► subscribePRODUCT NAME: TRAVOPROSTUM; NAT. REGISTRATION NO/DATE: LT 02/7821/3 20020402; FIRST REGISTRATION: EU/1/01/199/001 - EU/1/01/199/002 20011127
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc